Clinical trials in urological oncology: COVID-19 and the potential need for a new perspective.
World J Urol
; 39(9): 3147-3149, 2021 Sep.
Article
in English
| MEDLINE | ID: covidwho-743719
ABSTRACT
The COVID-19 pandemic has led to the suspension, termination or alteration of thousands of clinical trials as the health emergency escalated globally. Whilst the rapid suspension of certain clinical trials was necessary to ensure the safety of high-risk or vulnerable trial participants as well as healthcare workers, the long-term ramifications that this delay will have on the field of urologic oncology is unknown. The COVID-19 pandemic has highlighted the need to plan for and implement new strategies to advance our understanding of unmet areas of need in urologic oncology. The COVID-19 pandemic has led to the suspension, termination or alteration of thousands of clinical trials as the health emergency escalated globally. Whilst the rapid suspension of certain clinical trials was necessary to ensure the safety of high-risk or vulnerable trial participants as well as healthcare workers, the long-term ramifications that this delay will have on the field of urologic oncology is unknown. The COVID-19 pandemic has highlighted the need to plan for and implement new strategies to advance our understanding of unmet areas of need in urologic oncology.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Urology
/
Clinical Trials as Topic
/
COVID-19
/
Medical Oncology
Type of study:
Observational study
/
Prognostic study
/
Randomized controlled trials
Limits:
Humans
Language:
English
Journal:
World J Urol
Year:
2021
Document Type:
Article
Affiliation country:
S00345-020-03416-4
Similar
MEDLINE
...
LILACS
LIS